CVV reports weaker second-quarter 2025 results as revenue and earnings decline, while new system launch signals long-term growth focus.

VASO reports a second-quarter 2025 loss as lower imaging deliveries and rising costs pressured revenue and profit margins.

VASO reports a second-quarter 2025 loss as lower imaging deliveries and rising costs pressured revenue and profit margins.

TTSH reports lower second-quarter 2025 sales and margins as weaker store traffic and discounting pressured profitability.

TTSH reports lower second-quarter 2025 sales and margins as weaker store traffic and discounting pressured profitability.

EXK posts a Q2 loss despite a 46% rise in revenues, as higher costs and weaker gold output weigh on results.

bioAffinity shifts its focus on CyPath Lung as the second-quarter 2025 loss widens, with rising adoption and new market expansion underway.

bioAffinity shifts its focus on CyPath Lung as the second-quarter 2025 loss widens, with rising adoption and new market expansion underway.

BKTI posts strong second-quarter 2025 results with higher margins, rising federal demand and raised full-year earnings guidance.

NVFY's second-quarter 2025 loss narrows on improved margins, while sales dip due to continued furniture sector challenges.